rosiglitazone has been researched along with Heritable Pulmonary Arterial Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahsan, F; Al-Hilal, TA; Alobaida, A; Hammouda, S; McMurtry, IF; Nozik-Grayck, E; Rashid, J; Stenmark, KR | 1 |
| Dong, L; Han, D; Li, M; Li, S; Liu, L; Lu, J; Wang, G; Xie, X; Xu, J; Zhang, D; Zhang, Y | 1 |
| Fang, X; Fung, ML; Huang, Y; Liu, Y; Mao, G; Shyy, JY; Tian, XY; Wang, N | 1 |
3 other study(ies) available for rosiglitazone and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
Topics: Administration, Inhalation; Animals; Drug Carriers; Drug Compounding; Drug Liberation; Drug Repositioning; Familial Primary Pulmonary Hypertension; Humans; Hypoglycemic Agents; Male; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; PPAR gamma; Pulmonary Artery; Rats, Sprague-Dawley; Rosiglitazone; Treatment Outcome | 2018 |
Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
Topics: Animals; Blotting, Western; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Heme Oxygenase-1; Hypertension, Pulmonary; Hypoglycemic Agents; Immunoblotting; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2014 |
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Receptor, Serotonin, 5-HT2B; Rosiglitazone; Serotonin 5-HT2 Receptor Agonists; Thiazolidinediones; Thiophenes; Transcription Factor AP-1; Up-Regulation | 2012 |